Out-of-Pocket Costs and Prescription Reversals: the case of Oral Linezolid

Margaret K. Pasquale, Competitive Health Analytics
Anthony M. Louder, Competitive Health Analytics
Michael C. Deminski, Pfizer, Inc.
Richard B. Chambers, Pfizer, Inc.
Seema Haider, Pfizer, Inc.

8:45 AM - 9:30 AM

Modeling to assess value: Is it ready for prime time?

Jaime J. Caro, MDCM, FRCPC, FACP, McGill University Faculty of Medicine

9:30 AM - 10:15 AM